BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 31461932)

  • 1. Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis.
    Okano M; Oshi M; Butash AL; Katsuta E; Tachibana K; Saito K; Okayama H; Peng X; Yan L; Kono K; Ohtake T; Takabe K
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer.
    Oshi M; Tokumaru Y; Mukhopadhyay S; Yan L; Matsuyama R; Endo I; Takabe K
    Cells; 2021 Mar; 10(3):. PubMed ID: 33804148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cell-Based Systematic Review on the Role of Annexin A1 in Triple-Negative Breast Cancers.
    Pearanpan L; Nordin FJ; Siew EL; Kumolosasi E; Mohamad Hanif EA; Masre SF; Chua EW; Cheng HS; Rajab NF
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated Annexin A1 promotes cellular invasion in triple-negative breast cancer.
    Okano M; Kumamoto K; Saito M; Onozawa H; Saito K; Abe N; Ohtake T; Takenoshita S
    Oncol Rep; 2015 Mar; 33(3):1064-70. PubMed ID: 25592491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers.
    Chen L; Yuan Y; Kar S; Kanchi MM; Arora S; Kim JE; Koh PF; Yousef E; Samy RP; Shanmugam MK; Tan TZ; Shin SW; Arfuso F; Shen HM; Yang H; Goh BC; Park JI; Gaboury L; Lobie PE; Sethi G; Lim LHK; Kumar AP
    Mol Cancer Ther; 2017 Nov; 16(11):2528-2542. PubMed ID: 29021293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
    Bao X; Shi R; Zhao T; Wang Y; Anastasov N; Rosemann M; Fang W
    Cancer Immunol Immunother; 2021 Jan; 70(1):189-202. PubMed ID: 32681241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer.
    Bai F; Zhang P; Fu Y; Chen H; Zhang M; Huang Q; Li D; Li B; Wu K
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32300050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Triple-Negative Breast Cancer Cell Aggressiveness by Cathepsin D Blockage: Role of Annexin A1.
    Zóia MAP; Azevedo FVP; Vecchi L; Mota STS; Rodovalho VR; Cordeiro AO; Correia LIV; Silva ACA; Ávila VMR; Araújo TG; Goulart LR
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo.
    Vecchi L; Alves Pereira Zóia M; Goss Santos T; de Oliveira Beserra A; Colaço Ramos CM; França Matias Colombo B; Paiva Maia YC; Piana de Andrade V; Teixeira Soares Mota S; Gonçalves de Araújo T; Van Petten de Vasconcelos Azevedo F; Soares FA; Oliani SM; Goulart LR
    Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1368-1382. PubMed ID: 29932988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.
    Sobral-Leite M; Wesseling J; Smit VT; Nevanlinna H; van Miltenburg MH; Sanders J; Hofland I; Blows FM; Coulson P; Patrycja G; Schellens JH; Fagerholm R; Heikkilä P; Aittomäki K; Blomqvist C; Provenzano E; Ali HR; Figueroa J; Sherman M; Lissowska J; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Phillips KA; ; Couch FJ; Olson JE; Vachon C; Visscher D; Brenner H; Butterbach K; Arndt V; Holleczek B; Hooning MJ; Hollestelle A; Martens JW; van Deurzen CH; van de Water B; Broeks A; Chang-Claude J; Chenevix-Trench G; Easton DF; Pharoah PD; García-Closas M; de Graauw M; Schmidt MK
    BMC Med; 2015 Jul; 13():156. PubMed ID: 26137966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer.
    Oshi M; Newman S; Tokumaru Y; Yan L; Matsuyama R; Endo I; Nagahashi M; Takabe K
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro MIA PaCa-2 Model System.
    Pessolano E; Belvedere R; Bizzarro V; Franco P; Marco I; Porta A; Tosco A; Parente L; Perretti M; Petrella A
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC).
    Narrandes S; Huang S; Murphy L; Xu W
    BMC Cancer; 2018 Jan; 18(1):22. PubMed ID: 29301506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome Editing.
    Belvedere R; Saggese P; Pessolano E; Memoli D; Bizzarro V; Rizzo F; Parente L; Weisz A; Petrella A
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of
    Wang F; Cao X; Yin L; Wang Q; He Z
    DNA Cell Biol; 2020 Oct; 39(10):1813-1824. PubMed ID: 32816580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of annexin A1 expression by butyrate in human melanoma cells induces invasion by inhibiting E-cadherin expression.
    Shin J; Song IS; Pak JH; Jang SW
    Tumour Biol; 2016 Nov; 37(11):14577-14584. PubMed ID: 27612479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages correlate with phenomenon of epithelial-mesenchymal transition and contribute to poor prognosis in triple-negative breast cancer patients.
    Zhang WJ; Wang XH; Gao ST; Chen C; Xu XY; Sun Q; Zhou ZH; Wu GZ; Yu Q; Xu G; Yao YZ; Guan WX
    J Surg Res; 2018 Feb; 222():93-101. PubMed ID: 29273380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annexin-A1 regulates microRNA-26b* and microRNA-562 to directly target NF-κB and angiogenesis in breast cancer cells.
    Anbalagan D; Yap G; Yuan Y; Pandey VK; Lau WH; Arora S; Bist P; Wong JS; Sethi G; Nissom PM; Lobie PE; Lim LH
    PLoS One; 2014; 9(12):e114507. PubMed ID: 25536365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.
    Gastardelo TS; Cunha BR; Raposo LS; Maniglia JV; Cury PM; Lisoni FC; Tajara EH; Oliani SM
    PLoS One; 2014; 9(12):e111317. PubMed ID: 25490767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer.
    Karn T; Jiang T; Hatzis C; Sänger N; El-Balat A; Rody A; Holtrich U; Becker S; Bianchini G; Pusztai L
    JAMA Oncol; 2017 Dec; 3(12):1707-1711. PubMed ID: 28750120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.